Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2655)
All Articles published online
|
Mar 15, 2004 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li MS, Li PF, Chen Q, Du GG, Li G. Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells. World J Gastroenterol 2004; 10(6): 819-824 [PMID: 15040024 DOI: 10.3748/wjg.v10.i6.819] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i6/819.htm |
| Number | Citing Articles |
| 1 |
Yasushi Tamura, Satoshi Yamagiwa, Yohei Aoki, So Kurita, Takeshi Suda, Shogo Ohkoshi, Minoru Nomoto, Yutaka Aoyagi. Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C. Digestive Diseases and Sciences 2009; 54(11): 2530 doi: 10.1007/s10620-008-0642-y
|
| 2 |
Wenbo Meng, Xun Li, Zhongtian Bai, Yan Li, Jinqiu Yuan, Tao Liu, Jun Yan, Wence Zhou, Kexiang Zhu, Hui Zhang, Yumin Li, Keping Xie. Silencing Alpha-Fetoprotein Inhibits VEGF and MMP-2/9 Production in Human Hepatocellular Carcinoma Cell. PLoS ONE 2014; 9(2): e90660 doi: 10.1371/journal.pone.0090660
|
| 3 |
Yasi Pan, Huarong Chen, Jun Yu. Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives. Biomedicines 2020; 8(12): 576 doi: 10.3390/biomedicines8120576
|
| 4 |
Adriana Toro, Annalisa Ardiri, Maurizio Mannino, Maria Concetta Arcerito, Giovanni Mannino, Filippo Palermo, Gaetano Bertino, Isidoro Di Carlo. Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study. BMC Surgery 2014; 14(1) doi: 10.1186/1471-2482-14-40
|
| 5 |
Suqin Shen, Huan Feng, Longjiang Liu, Wei Su, Long Yu, Jiaxue Wu. TCP10L negatively regulates alpha-fetoprotein expression in hepatocellular carcinoma. BMB Reports 2020; 53(8): 431 doi: 10.5483/BMBRep.2020.53.8.008
|
| 6 |
A. A. Terentiev, N. T. Moldogazieva. Alpha-fetoprotein: a renaissance. Tumor Biology 2013; 34(4): 2075 doi: 10.1007/s13277-013-0904-y
|
| 7 |
Yee Hui Yeo, Yi-Te Lee, Hsian-Rong Tseng, Yazhen Zhu, Sungyong You, Vatche G. Agopian, Ju Dong Yang. Alpha-fetoprotein: Past, present, and future. Hepatology Communications 2024; 8(5) doi: 10.1097/HC9.0000000000000422
|
| 8 |
Ya-jun Ren, Tao Huang, Hong-lu Yu, Li Zhang, Qian-jin He, Zhi-fan Xiong, Hua Peng. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein. Journal of Huazhong University of Science and Technology [Medical Sciences] 2016; 36(6): 846 doi: 10.1007/s11596-016-1673-9
|
| 9 |
Mingyue Zhu, Junli Guo, Hua Xia, Wei Li, Yan Lu, Xu Dong, Yi Chen, Xieju Xie, Shigan Fu, Mengsen Li. Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells. Oncoscience 2015; 2(1): 59 doi: 10.18632/oncoscience.115
|
| 10 |
Elyse A Linson, Stephen B Hanauer. More Than a Tumor Marker…A Potential Role for Alpha-Feto Protein in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; 25(7): 1271 doi: 10.1093/ibd/izy394
|
| 11 |
Xiaoping Wang, Qiaoxia Wang. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/9049252
|
| 12 |
Chao He, Xiaoyun Zhang, Chuan Li, Wei Peng, Tian-Fu Wen, Lv-Nan Yan, Jiayin Yang, Wusheng Lu. Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization. Oncotarget 2017; 8(49): 85599 doi: 10.18632/oncotarget.20343
|
| 13 |
Tianke Chen, Xiaowei Dai, Juji Dai, Chaodong Ding, Zheng Zhang, Ziqi Lin, Jin Hu, Mei Lu, Zhanyu Wang, Yalei Qi, Li Zhang, Rulu Pan, Zhu Zhao, Liting Lu, Wanqin Liao, Xincheng Lu. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Cell Death & Disease 2020; 11(10) doi: 10.1038/s41419-020-03030-7
|
| 14 |
Yun-Han Lee, Ik-Jae Moon, Bin Hur, Jeong-Hoh Park, Kil-Hwan Han, Seok-Yong Uhm, Yong-Joo Kim, Koo-Jeong Kang, Jong-Wook Park, Young-Bae Seu, Young-Ho Kim, Jong-Gu Park. Gene knockdown by large circular antisense for high-throughput functional genomics. Nature Biotechnology 2005; 23(5): 591 doi: 10.1038/nbt1089
|
| 15 |
Lu Zheng, Wei Gong, Ping Liang, XiaoBing Huang, Nan You, Ke Qiang Han, Yu Ming Li, Jing Li. Effects of AFP-activated PI3K/Akt signaling pathway on cell proliferation of liver cancer. Tumor Biology 2014; 35(5): 4095 doi: 10.1007/s13277-013-1535-z
|
| 16 |
Nihal Mostafa, Ahmed Salem, Somaya Z. Mansour, Sawsan M. El-Sonbaty, Fatma S. M. Moawed, Eman I. Kandil. Rationale for Tailoring an Alternative Oncology Trial Using a Novel Gallium-Based Nanocomplex: Mechanistic Insights and Preclinical Challenges. Technology in Cancer Research & Treatment 2022; 21: 153303382210853 doi: 10.1177/15330338221085376
|
| 17 |
Haruhiko Kobashi, Yasuhiro Miyake, Fusao Ikeda, Tetsuya Yasunaka, Ken Nishino, Akio Moriya, Jyunichi Kubota, Shinichiro Nakamura, Akinobu Takaki, Kazuhiro Nouso, Gotaro Yamada, Kazuhide Yamamoto. Long‐term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine. Hepatology Research 2011; 41(5): 405 doi: 10.1111/j.1872-034X.2011.00785.x
|
| 18 |
Ye Xu, Qinglong Guo, Libin Wei. The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma. Cancers 2021; 13(20): 5096 doi: 10.3390/cancers13205096
|
| 19 |
Mark J. Hoenerhoff, Arun R. Pandiri, Stephanie A. Lahousse, Hu-Hua Hong, Tai-Vu Ton, Tiwanda Masinde, Scott S. Auerbach, Kevin Gerrish, Pierre R. Bushel, Keith R. Shockley, Shyamal D. Peddada, Robert C. Sills. Global Gene Profiling of Spontaneous Hepatocellular Carcinoma in B6C3F1 Mice. Toxicologic Pathology 2011; 39(4): 678 doi: 10.1177/0192623311407213
|
| 20 |
Sun Yuping, Ma Xiaoli, Wang Yunshan, Hu Anla. Downregulation of AFP Protein Expression by RNAi Inhibits the Growth of AFP-Producing Gastric Adenocarcinoma Cell Line. 2007 1st International Conference on Bioinformatics and Biomedical Engineering 2007; : 45 doi: 10.1109/ICBBE.2007.15
|
| 21 |
Gerald J. Mizejewski. Physiology of Alpha-Fetoprotein as a Biomarker for Perinatal Distress: Relevance to Adverse Pregnancy Outcome. Experimental Biology and Medicine 2007; 232(8): 993 doi: 10.3181/0612-MR-291
|
| 22 |
Mingyue Zhu, Junli Guo, Wei Li, Hua Xia, Yan Lu, Xu Dong, Yi Chen, Xieju Xie, Shigan Fu, Mengsen Li. HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cells. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1384-9
|
| 23 |
Xiaonan Ji, Yanli Shen, Hao Sun, Xiangdong Gao. A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel. Tumor Biology 2016; 37(8): 10085 doi: 10.1007/s13277-016-4803-x
|
| 24 |
M. Muehlemann, K. D. Miller, M. Dauphinee, G. J. Mizejewski. Review of Growth Inhibitory Peptide as a Biotherapeutic agent for tumor growth, adhesion, and metastasis. Cancer and Metastasis Reviews 2005; 24(3): 441 doi: 10.1007/s10555-005-5135-2
|
| 25 |
Chao He, Wei Peng, Xiaojuan Liu, Chuan Li, Xueting Li, Tian-Fu Wen. Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma. Medicine 2019; 98(31): e16557 doi: 10.1097/MD.0000000000016557
|
| 26 |
Yan Lu, Bo Lin, Mengsen Li. The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1363695
|
| 27 |
Janneta Tcherkassova, Sergei Tsurkan, Galina Smirnova, Julia Borisova, Ricardo Moro, Helen Treshalina. Binding characterization of the targeting drug AIMPILA to AFP receptors in human tumor xenografts. Tumor Biology 2017; 39(10): 101042831773481 doi: 10.1177/1010428317734815
|
| 28 |
JING HU, NA ZHANG, RONGLIN WANG, FEI HUANG, GUANG LI. Paclitaxel induces apoptosis and reduces proliferation by targeting epidermal growth factor receptor signaling pathway in oral cavity squamous cell carcinoma. Oncology Letters 2015; 10(4): 2378 doi: 10.3892/ol.2015.3499
|
| 29 |
Mengsen Li, Sheng Zhou, Xinhua Liu, Pingfeng Li, Michael A. McNutt, Gang Li. α-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Letters 2007; 249(2): 227 doi: 10.1016/j.canlet.2006.09.004
|
| 30 |
Bo Lin, Xu Dong, Qiujiao Wang, Wei Li, Mingyue Zhu, Mengsen Li. AFP-Inhibiting Fragments for Drug Delivery: The Promise and Challenges of Targeting Therapeutics to Cancers. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.635476
|
| 31 |
Rita Ammoury, Roula Tahtouh, Nadine Mahfouz, Raia Doumit, Charbel Khalil, George Hilal. Relationship between Protein kinase C isoforms, Telomerase and Alpha-fetoprotein through PI3K/AKT/mTOR pathway in Hepatocellular carcinoma. MedPharmRes 2021; 5(4): 12 doi: 10.32895/UMP.MPR.5.4.3
|
| 32 |
Mengsen Li, Hui Li, Chaoying Li, Shanshan Wang, Wei Jiang, Zhongmin Liu, Sheng Zhou, Xinhua Liu, Michael A. McNutt, Gang Li. Alpha‐fetoprotein: A new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines. International Journal of Cancer 2011; 128(3): 524 doi: 10.1002/ijc.25373
|
| 33 |
Min Luo, Fan Yang, Sheng-xin Huang, Zhi-peng Kuang, Xiao-ling Luo, Yuan-dong Li, Ji-ning Wu, Yu-an Xie. Two-Stage Model of Chemically Induced Hepatocellular Carcinoma in Mouse. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2012; 20(11): 517 doi: 10.3727/096504013X13747716581336
|
| 34 |
Wei Li, Kun Liu, Yi Chen, Mingyue Zhu, Mengsen Li. Role of Alpha-Fetoprotein in Hepatocellular Carcinoma Drug Resistance. Current Medicinal Chemistry 2021; 28(6): 1126 doi: 10.2174/0929867327999200729151247
|
| 35 |
Mengsen Li, Hui Li, Chaoying Li, Liyuan Guo, Han Liu, Sheng Zhou, Xinhua Liu, Zhuo Chen, Shuanglin Shi, Jiang Wei, Michael A. McNutt, Gang Li. Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells. Cancer Letters 2009; 285(2): 190 doi: 10.1016/j.canlet.2009.05.014
|
| 36 |
Young Ju Lee, Seong-Wook Lee. Regression of hepatocarcinoma cells using RNA aptamer specific to alpha-fetoprotein. Biochemical and Biophysical Research Communications 2012; 417(1): 521 doi: 10.1016/j.bbrc.2011.11.153
|
| 37 |
Li Zhou, Jing-An Rui, Shao-Bin Wang, Shu-Guang Chen, Qiang Qu. Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2013; 12(1): 68 doi: 10.1016/S1499-3872(13)60008-9
|
| 38 |
Mengsen Li, Hui Li, Chaoying Li, Sheng Zhou, Liyuan Guo, Han Liu, Wei Jiang, Xinhua Liu, Pingfeng Li, Michael A. McNutt, Gang Li. Alpha fetoprotein is a novel protein‐binding partner for caspase‐3 and blocks the apoptotic signaling pathway in human hepatoma cells. International Journal of Cancer 2009; 124(12): 2845 doi: 10.1002/ijc.24272
|
| 39 |
Roula Tahtouh, Anne-Sophie Azzi, Nada Alaaeddine, Soulaima Chamat, Hasnaa Bouharoun-Tayoun, Layal Wardi, Issam Raad, Riad Sarkis, Najibe Abou Antoun, George Hilal, Diego Calvisi. Telomerase Inhibition Decreases Alpha-Fetoprotein Expression and Secretion by Hepatocellular Carcinoma Cell Lines: In Vitro and In Vivo Study. PLOS ONE 2015; 10(3): e0119512 doi: 10.1371/journal.pone.0119512
|
| 40 |
A. A. Terentiev, N. T. Moldogazieva. Cell adhesion proteins and α-fetoprotein. Similar structural motifs as prerequisites for common functions. Biochemistry (Moscow) 2007; 72(9): 920 doi: 10.1134/S0006297907090027
|
| 41 |
Xiaojun Yang, Youcheng Zhang, Lingyi Zhang, Lin Zhang, Jie Mao. Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell. Cancer Letters 2008; 271(2): 281 doi: 10.1016/j.canlet.2008.06.017
|
| 42 |
Hidetoshi Gon, Masahiro Kido, Motofumi Tanaka, Hisoka Kinoshita, Shohei Komatsu, Daisuke Tsugawa, Masahide Awazu, Hirochika Toyama, Ippei Matsumoto, Tomoo Itoh, Takumi Fukumoto. Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma. Surgery 2018; 164(5): 1014 doi: 10.1016/j.surg.2018.06.025
|